Replies to post #3087 on Oncolix Inc. (fka ONCX)

[ninersax]

Yup. However, it is wise to expect the worse to protect your investment. Rarely and I mean rarely do R/S's benefit shareholders.

With all this, Oncolix is only as good as the product it is trying to bring to the market. If Prolanta fails phase 2 efficacy tests, then Oncolix will be worth squat.

All bio-techs at this stage are mostly valuated with speculation.